UnknownNot Applicable

Lactate Metabolism in the Hypoperfused Critically Ill

Denmark20 participantsStarted 2022-09-15

Plain-language summary

Investigating lactate metabolism in critically ill patients whom are hypoperfused by preforming metabolomics via liquid chromatography-mass spectrometry.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with sepsis/septic shock or severe heart failure. * Clinical and paraclinical signs of hypoperfusion in relation to abovementioned diagnosis. * Metabolic acidosis with s-lactate equal-to-or-above 4 mmol/l. * Incapacitated Exclusion Criteria: * Only regional hypoperfusion such as a leg. * Receiving intravenous lactate as part of treatment. * Going in to dialysis. The exclusion is only during dialysis treatment.

What they're measuring

Laktate levels in blood

Timeframe: Daily testing. Average time frame for the paticipants are 3 days (ranging from 1-10 days).

Trial details

NCT IDNCT05582824

SponsorUniversity of Copenhagen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-11

Contact for this trial

Henrik Wolsted, MD

+4521494485 henrik.wolsted01@regionh.dk

View on ClinicalTrials.gov More Lactate trials